Logic-Gated Bioorthogonal In Situ Synthesis of Proteolysis-Targeting Chimeras for Precise Protein Degradation and Synergistic Immunotherapy
Source abstract
Abstract
Targeting glutathione peroxidase 4 (GPX4) with traditional small-molecule inhibitors or conventional proteolysis-targeting chimeras (PROTACs) is limited by uncontrollable systemic toxicity. To overcome this, we engineered a nanosystem (GV@Ce6–Cu, GVCC) centered on the bioorthogonal in situ synthesis of a PROTAC, strictly governed by a tumor microenvironment (TME)-specific “AND” logic gate responsive to both overexpressed cathepsin B (CTSB) and elevated glutathione (GSH). Within the TME, CTSB specifically cleaves a peptide precursor into functional fragments, while GSH simultaneously reduces a codelivered Cu 2+ to the active Cu + catalyst. Only the concurrent action of both inputs enables the bioorthogonal ligation of the fragments in situ to form the active GPX4-degrading PROTAC. This precise synthesis orchestrates a cascade of functions. The in situ-generated PROTAC initiates ferroptosis by degrading GPX4; this effect is powerfully amplified by coreleased copper ions (driving cuproptosis) and by chlorin e6 (Ce6)-mediated photodynamic therapy (PDT), which together generate a massive reactive oxygen species burst. This cooperative induction of ferroptosis and cuproptosis, augmented by PDT, triggers robust immunogenic cell death. Consequently, GVCC treatment reprograms the immunosuppressive triple-negative breast cancer microenvironment and demonstrates potent synergy with anti-PD-L1 checkpoint blockade. This study establishes bioorthogonal in situ PROTAC synthesis as an effective precision strategy for cancer therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Click Chemistry and Applications · Chemical Synthesis and Analysis · Protein Degradation and Inhibitors
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, College of Sciences, School of Medicine
Shanghai University
Institute of Translational Medicine
Shanghai Jiao Tong University
Shanghai Integration and Innovation Center of Marine Medical Engineering
School of Pharmacy
Chengdu Medical College
Funding
National Natural Science Foundation of China
References (45)
Show source-provided references
1. 10.1186/s13045-023-01497-310.1186/s13045-023-01497-3 ↗
2. 10.1158/1538-7445.AM2025-162910.1158/1538-7445.AM2025-1629 ↗
3. 10.1038/s41571-021-00565-210.1038/s41571-021-00565-2 ↗
4. 10.1038/s41556-025-01640-x10.1038/s41556-025-01640-x ↗
5. 10.1002/adhm.20250386910.1002/adhm.202503869 ↗
6. 10.1016/j.cmet.2022.09.02110.1016/j.cmet.2022.09.021 ↗
7. 10.1038/s41422-020-00441-110.1038/s41422-020-00441-1 ↗
8. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
9. 10.1016/j.freeradbiomed.2025.04.00610.1016/j.freeradbiomed.2025.04.006 ↗
10. 10.1002/adfm.20252164110.1002/adfm.202521641 ↗
11. 10.1002/adma.20250143510.1002/adma.202501435 ↗
12. 10.1038/s41467-024-45635-y10.1038/s41467-024-45635-y ↗
13. 10.1038/s41571-023-00736-310.1038/s41571-023-00736-3 ↗
14. 10.1002/anie.20241414610.1002/anie.202414146 ↗
15. 10.1039/D2CS00200K10.1039/D2CS00200K ↗
16. 10.1021/acsnano.4c1190310.1021/acsnano.4c11903 ↗
17. 10.1002/adma.20251697410.1002/adma.202516974 ↗
18. 10.1021/jacs.5c1594510.1021/jacs.5c15945 ↗
19. 10.1002/anie.20242171310.1002/anie.202421713 ↗
20. 10.1016/j.mtbio.2025.10152310.1016/j.mtbio.2025.101523 ↗
21. 10.1002/anie.20211495710.1002/anie.202114957 ↗
22. 10.1016/j.ejmech.2022.11508210.1016/j.ejmech.2022.115082 ↗
23. 10.1002/anie.20230839610.1002/anie.202308396 ↗
24. 10.1038/s41568-021-00363-z10.1038/s41568-021-00363-z ↗
25. 10.1002/mco2.7004810.1002/mco2.70048 ↗
26. 10.1158/2159-8290.cd-20-180810.1158/2159-8290.cd-20-1808 ↗
27. 10.1021/jacs.5c0013110.1021/jacs.5c00131 ↗
28. 10.1016/j.biomaterials.2022.12190610.1016/j.biomaterials.2022.121906 ↗
29. 10.1002/anie.20250992410.1002/anie.202509924 ↗
30. 10.1038/s41467-024-55658-010.1038/s41467-024-55658-0 ↗
31. 10.1016/j.biomaterials.2025.12326110.1016/j.biomaterials.2025.123261 ↗
32. 10.1002/adfm.20240858110.1002/adfm.202408581 ↗
33. 10.1016/j.chempr.2024.06.00410.1016/j.chempr.2024.06.004 ↗
34. 10.7150/thno.7544410.7150/thno.75444 ↗
35. 10.1021/jacs.5c0704110.1021/jacs.5c07041 ↗
36. 10.1016/j.actbio.2025.04.02310.1016/j.actbio.2025.04.023 ↗
37. 10.1021/jacs.4c0082610.1021/jacs.4c00826 ↗
38. 10.1016/j.cej.2025.16745510.1016/j.cej.2025.167455 ↗
39. 10.1016/j.bbrc.2016.11.03510.1016/j.bbrc.2016.11.035 ↗
40. 10.1038/s41467-025-65074-710.1038/s41467-025-65074-7 ↗
41. 10.1038/s41392-024-01983-110.1038/s41392-024-01983-1 ↗
42. 10.1002/cac2.7006410.1002/cac2.70064 ↗
43. 10.1002/anie.20242501810.1002/anie.202425018 ↗
44. 10.1016/j.mattod.2024.03.01710.1016/j.mattod.2024.03.017 ↗
45. 10.1002/adma.20241297410.1002/adma.202412974 ↗